Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities
✍ Scribed by Miroslav Djokic; Michelle M. Le Beau; Lode J. Swinnen; Sonali M. Smith; Charles M. Rubin; John Anastasi; Katrin M. Carlson
- Book ID
- 102220580
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 124 KB
- Volume
- 45
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although cytogenetic analysis advanced the understanding of the pathogenesis of primary non‐Hodgkin lymphoma and led to improved clinical management, there have been no large cytogenetic studies of post‐transplant lymphoproliferative disorder (PTLD). We examined the karyotypes of 36 PTLD cases and correlated them with clinical, laboratory, and pathologic findings. The cases included 2 early lesions, 13 polymorphic PTLDs, and 21 monomorphic PTLDs (18 B‐cell and 3 T‐cell proliferations). Cytogenetic abnormalities were identified in 72% of monomorphic B‐cell PTLDs and in all T‐cell PTLDs, but in only 15% of polymorphic PTLDs and in no early lesions. The most frequent clonal abnormalities in monomorphic PTLD were trisomies 9 and/or 11 (5 cases), followed by rearrangements of 8q24.1 (4 cases), 3q27 (2 cases), and 14q32 (2 cases). MYC rearrangement (8q24.1) and T‐cell‐associated chromosomal abnormalities correlated with poor outcome and short survival. PTLD with trisomy 9 and/or 11 developed early after transplant, presenting as Epstein–Barr virus–positive large B‐cell lymphoma with prolonged survival. © 2005 Wiley‐Liss, Inc.